SpeechVive, a Lafayette, Ind.- and Fort Wayne, Ind.-based developer of a speech aid device for people with Parkinson’s disease, completed a nearly $700k in Series A funding.
Backers included Ambassador Enterprises.
The company intends to use the funds to support the U.S. sales launch of the device.
Led by Steve Mogensen, president and CEO, SpeechVive provides a a behind-the-ear smart device for people with Parkinson’s disease to speak more loudly and communicate more effectively.
The technology was developed over the past decade by Jessica Huber, associate professor in Purdue University’s Department of Speech, Language and Hearing Sciences, who had previously received $2.25m in funding from the National Institutes of Health (NIH).